Gland Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 11, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	313,762	262,358	303,932	208,882	537,705	405,432
Market Cap Growth	31.39%	-13.68%	45.50%	-61.15%	32.63%	-
Enterprise Value	284,766	236,321	286,055	175,977	508,469	390,204
Last Close Price	1904.40	1577.70	1809.55	1243.71	3209.33	2430.35
PE Ratio	37.04	37.56	39.35	26.74	44.38	40.67
Forward PE	29.15	27.55	29.26	17.57	35.96	34.98
PS Ratio	5.13	4.67	5.37	5.76	12.22	11.71
PB Ratio	3.28	2.87	3.48	2.63	7.51	6.87
P/TBV Ratio	3.42	2.98	3.63	2.63	7.53	6.87
P/FCF Ratio	-	49.48	50.08	146.03	192.42	107.78
P/OCF Ratio	-	28.68	30.49	57.39	68.00	67.02
PEG Ratio	0.98	1.60	1.58	1.59	1.44	1.53
EV/Sales Ratio	4.66	4.21	5.05	4.86	11.55	11.27
EV/EBITDA Ratio	19.81	19.19	22.06	17.07	33.67	29.97
EV/EBIT Ratio	27.53	27.10	29.45	19.90	36.32	32.42
EV/FCF Ratio	-	44.57	47.14	123.03	181.96	103.74
Debt / Equity Ratio	0.03	0.03	0.04	0.00	0.00	0.00
Debt / EBITDA Ratio	0.21	0.25	0.28	0.00	0.00	0.00
Debt / FCF Ratio	-	0.59	0.61	0.03	0.02	0.01
Net Debt / Equity Ratio	-0.30	-0.29	-0.18	-0.47	-0.45	-0.51
Net Debt / EBITDA Ratio	-2.04	-2.14	-1.21	-3.64	-2.15	-2.30
Net Debt / FCF Ratio	-	-4.98	-2.58	-26.27	-11.60	-7.97
Asset Turnover	-	0.51	0.58	0.44	0.61	0.65
Inventory Turnover	-	1.44	1.40	1.16	1.79	1.56
Quick Ratio	-	3.01	2.61	6.58	7.80	7.31
Current Ratio	-	4.34	4.04	9.46	10.06	10.00
Return on Equity (ROE)	-	7.82%	9.26%	10.33%	18.55%	20.88%
Return on Assets (ROA)	-	4.98%	6.25%	6.65%	12.21%	14.22%
Return on Invested Capital (ROIC)	10.55%	8.39%	11.67%	16.14%	30.73%	34.27%
Return on Capital Employed (ROCE)	-	9.00%	10.50%	11.00%	19.30%	20.10%
Earnings Yield	2.70%	2.66%	2.54%	3.74%	2.25%	2.46%
FCF Yield	-	2.02%	2.00%	0.69%	0.52%	0.93%
Dividend Yield	0.95%	1.14%	1.10%	-	-	-
Payout Ratio	-	47.17%	-	-	-	-
Buyback Yield / Dilution	-0.02%	-0.01%	-0.03%	-0.09%	-3.96%	-2.15%
Total Shareholder Return	0.93%	1.13%	1.07%	-0.09%	-3.96%	-2.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.